Network analysis further reveals that Prunella vulgaris L. produces therapeutic effects on breast cancer by inhibiting key targets in the ErbB signaling pathway and estrogen signaling pathways, such as AKT1, EGFR, and MYC. The gene discussed is MYC; the disease is breast carcinoma.